Locations:
Search IconSearch

Offering Rehabilitation Care to Oncology Patients (Podcast)

New oncologic rehab program is tailored to managing the effects of cancer and its treatments

Oncology patients face an array of adverse effects from their cancer and its treatments, including pain, mobility issues and cognitive impairment. Eileen Slavin, DO, a physician in the Department of Physical Medicine and Rehabilitation within Cleveland Clinic’s Neurological Institute, recently launched an oncologic rehabilitation program to help patients maintain and regain function during their cancer treatment and recovery.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“All of us have been affected by cancer in some way — through patients that we treat or family members,” Dr. Slavin says. “That’s why I’m excited about this work — it’s really important. I appreciate the collaboration of the diverse teams that are involved — all of our oncology teams, all our therapy teams, neurology, prosthetics and orthotics, nutrition and others.”

In a recent episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Slavin discusses the emerging field of cancer rehabilitation. The topics she covers include:

  • What oncologic rehabilitation entails, and how to refer patients
  • The difference between palliative care and rehabilitation
  • The role of prehabilitation to prepare patients prior to surgery and other treatments
  • Consulting on the care of patients with side effects such as fatigue from chemotherapy and neurotoxicity from immunotherapies

Click the podcast player above to listen to the 25-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™ and ANCC contact hours. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: I suspect that one real growth area for you will be prehabilitation. Can you explain prehabilitation and what your role in it is?

Dr. Slavin: The concept of prehabilitation is for patients to prepare for something like a transplant or a big surgery, particularly when we know the outcomes could be potentially devastating — for instance, that they could end up with lymphedema, could have major mobility issues, could lose a lot of weight or might have a lower functional status. We try to identify patients who have about four to six weeks until their surgery or their transplant. That is better, of course, for solid tumor patients undergoing neoadjuvant chemotherapy because we can buy some time.

Advertisement

Prehabilitation essentially involves optimizing patients from three different perspectives — psychologically, physically and nutritionally. It includes looking at psychological health — referring patients to psychology, making sure they have good psychosocial support, such as ensuring that they have no transportation issues. It also includes helping with physical activity, or the physical function piece. That involves talking about exercise counseling, providing safety recommendations, giving them actual exercise prescriptions using the principle of FITT, or frequency, intensity, time and type. Then the final piece is nutrition, which involves collaborating with our dietician colleagues to prepare for the likelihood that the patient will lose weight and to make plans to help the patient maintain their caloric intake and consume enough protein to reduce loss of muscle mass and avoid sarcopenia.

All these aspects of the patient’s life will be affected. The idea of prehabilitation is to build the patient up before they get beaten up with all these therapies to treat their cancer, so that they have a stronger baseline to start from and will have a better and swifter recovery from treatment.

Advertisement

Related Articles

Dr. Holly Pederson
July 25, 2024/Cancer/Research
Evaluating Risk Scores for Triple-Negative Breast Cancer in Black Women (Podcast)

Polygenic risk score could help predict who will develop this aggressive breast cancer

Dr. AlHilli
July 3, 2024/Cancer/Patient Support
Prehabilitation Program Aims to Improve Outcomes for Older Patients with Ovarian or Pancreatic Cancer

Clinical trial to assess the value of nutritional, physical therapy and social supports prior to preoperative chemotherapy

woman on stationary exercise cycle
July 1, 2024/Neurosciences/PM&R
New Trial to Assess Forced Exercise for Subacute Stroke Recovery

Research to test clinical efficacy and cost-effectiveness versus standard-of-care rehab

Image showing Dr. Gupta
June 20, 2024/Cancer/Research
Trailblazing Urothelial Cancer Treatments (Podcast)

Platinum-eligible phase 3 trial of enfortumab vedotin and pembrolizumab yields ‘unprecedented data’

Patient taking medication
May 22, 2024/Digestive/Research
Study Finds No Connection Between OSMs and Increased Cancer Rates in IBD Patients

Reassuring results, but patient education is still important

Cleveland Clinic physiatrist
March 22, 2024/Cancer/Innovations
The Vital Role of Oncology Rehabilitation (Podcast)

New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function

Surgeons operating robotically
Transoral Robotic Surgery to Treat Head and Neck Cancer (Podcast)

A new single-port system well-suited for oropharyngeal cancer treatment

24-CNR-4545611-CQD-Podcast-967×544
February 1, 2024/Cancer/Research
Possibilities of CRISPR Technology (Podcast)

Gene editing technology offers promise for treating multiple myeloma and other hematologic malignancies, as well as solid tumors

Ad